1. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma
   Rui Zhang et al, 2016, Molecular Neurobiology CrossRef
2. Mir-221/222 are promising targets for innovative anticancer therapy
   Maria Teresa Di Martino et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines
   Lucy Wanjiku Macharia et al, 2021, BMC Cancer CrossRef
4. MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
   Rui Chen et al, 2016, Biology Open CrossRef
5. MicroRNA in Glioblastoma: An Overview
   Barbara Banelli et al, 2017, International Journal of Genomics CrossRef
6. Role of microRNAs in glioblastoma
   Ming Chen et al, 2021, Oncotarget CrossRef
7. Is There a Best Radiosensitizing Agent in the Treatment of Locally Advanced Rectal Cancer?
   Andrew L. Coveler et al, 2016, Current Colorectal Cancer Reports CrossRef
8. Prognostic Role of MicroRNA 222 in Patients with Glioma: A Meta-analysis
   Yanlin Song et al, 2020, BioMed Research International CrossRef
9. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
   Charles Holjencin et al, 2022, Cells CrossRef
10. Prediction of clinical outcome in glioblastoma using a biologically relevant nine‐microRNA signature
    Josie Hayes et al, 2015, Molecular Oncology CrossRef
11. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies
    Andrea Diana et al, 2020, International Journal of Molecular Sciences CrossRef
12. Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications
    Uswa Shahzad et al, 2021, Cancers CrossRef
13. Autophagy Intervened by MicroRNAs Causes Gliomas
    Trupti Trivedi, 2023, Journal of Neuro and Oncology Research CrossRef
14. The molecular mechanisms of drug resistance of glioblastoma: differentiation and apoptosis
    A. N. Chernov et al, 2024, Russian Journal for Personalized Medicine CrossRef
15. Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors
    Agnieszka Bronisz et al, 2016, Cellular and Molecular Neurobiology CrossRef
16. The molecular mechanisms of drug resistance of glioblastoma. Part 3. Differentiation and apoptosis of glioblastoma cells
    Alexander N. Chernov et al, 2023, Medical academic journal CrossRef
17. Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates
    Santiago Grijalvo et al, 2018, Genes CrossRef
18. Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
    Jialin Song et al, 2017, Frontiers in Immunology CrossRef
19. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma
    Xinxing Li et al, 2016, Molecular Neurobiology CrossRef
20. Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods
    Jessyca Aparecida Paes Dutra et al, 2022, Current Pharmaceutical Design CrossRef
21. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma
    Jian-Kai Yang et al, 2017, Journal of Neuro-Oncology CrossRef
22. MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives
    Rajni Shaw et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef